Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.015748031496063 0.0145669291338582
Stock impact report

Galectin Therapeutics’ President and CEO Dr. Harold Shlevin to Present at the 3rd Global NASH Congress 2020

Galectin Therapeutics, Inc (GALT)  More Company Research Source: GlobeNewswire
Last galectin therapeutics, inc earnings: 11/12 08:00 am Check Earnings Report
PDF NORCROSS, Ga., Feb. 04, 2020 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc.(NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold H. Shlevin, the Company’s President and CEO, will present at the 3rd Global NASH Congress 2020 at the London Heathrow Marriott on Tuesday, February 11, at 3:00 p.m. (15:00) local time. In his presentation, titled “Clinical development of belapectin (GR-MD-02), a galectin-3 inhibitor, in treatment of NASH cirrhosis,” Dr. Shlevin will discuss how Galectin-3 inhibition has been shown to be central to the fibrotic process involved in the development of NASH-related cirrhosis, and how belapectin (GR-MD-02), the company’s galectin-3 inhibitor, has been demonstrated in a Phase 2b trial to decrease hepatic venous pressure gradient in compensated NASH cirrhotic patients without varices at baseline. Dr. Shlevin will also outline how the results of Galectin’s Phase 2 clinical trial have provided guidance [Read more]
Impact snapshot Event time: GALT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
GALT alerts
from News Quantified
Opt-in for
GALT alerts

from News Quantified
Opt-in for
GALT alerts

from News Quantified